1. Home
  2. FBRT vs CTMX Comparison

FBRT vs CTMX Comparison

Compare FBRT & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin BSP Realty Trust Inc.

FBRT

Franklin BSP Realty Trust Inc.

SELL

Current Price

$6.18

Market Cap

695.9M

Sector

Real Estate

ML Signal

SELL

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

SELL

Current Price

$2.35

Market Cap

716.9M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
FBRT
CTMX
Founded
2012
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
695.9M
716.9M
IPO Year
2012
2015

Fundamental Metrics

Financial Performance
Metric
FBRT
CTMX
Price
$6.18
$2.35
Analyst Decision
Buy
Strong Buy
Analyst Count
5
8
Target Price
$11.67
★ $12.25
AVG Volume (30 Days)
2.1M
★ 3.9M
Earning Date
10-28-2026
11-05-2026
Dividend Yield
★ 13.07%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.19
N/A
Revenue
★ $270,071,000.00
$76,201,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$9.88
$1.24
P/E Ratio
$32.21
★ $22.58
Revenue Growth
★ 28.33
N/A
52 Week Low
$6.03
$2.41
52 Week High
$10.88
$8.21

Technical Indicators

Market Signals
Indicator
FBRT
CTMX
Relative Strength Index (RSI) 24.64 30.18
Support Level N/A N/A
Resistance Level $9.32 $3.93
Average True Range (ATR) 0.24 0.13
MACD -0.03 -0.01
Stochastic Oscillator 6.92 8.61

Price Performance

Historical Comparison
FBRT
CTMX

About FBRT Franklin BSP Realty Trust Inc.

Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States. The Company's operations are organized into two business units: (i) Commercial Real Estate Financing, and (ii) Agency Business. Its four reporting segments are as follows: The real estate debt business, The Agency Business, The commercial real estate conduit business, and The real estate owned business.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: